Hledání v detailu akcií
Moje portfolio
Nastavit Oblíbené, nastavit Portfolio
Oblíbené tituly
select
NázevNejlepší
nákup
Nejlepší
prodej
Změna
(%)
ČEZ0,17
KB998,5-1,63
PKN77,577,540,91
Msft1,32
Nokia4,5774,635-0,67
IBM-0,17
Mercedes-Benz Group AG51,6451,66-0,71
PFE1,47
12.06.2025 23:28:58
Indexy online
AD Index online
select
AD Index online
 

  • 12.06.2025 21:59:30
USANA Hlth Sci (USNA.K, NY Consolidated)
Poslední obchod Změna (%) Změna (USD) Objem obchodů (ks)
29,76 -0,32 -0,10 59 017
After-hours12.06.2025 23:05:00
Poslední obchod Nákup / Prodej Změna (%) Změna (USD)
29,78 - - -0,23 -0,07
R - Real-Time data si mohou aktivovat klienti Patria Plus / Investor Plus ZDE.

 
  • Poslední aktualizace: 12.06.2025
Popis společnosti
Obecné informace
Název společnostiUSANA Health Sciences Inc
TickerUSNA
Kmenové akcie:Ordinary Shares
RICUSNA.K
ISIN-
Poslední známé roční výsledky28.12.2024
Poslední známé čtvrtletní výsledky29.03.2025
Počet zaměstnanců k 28.12.2024 1 700
Akcie v oběhu k 02.05.2025 18 623 075
MěnaUSD
Konstituent indexůS&P 600 Small Cap
Kontaktní informace
Ulice3838 W Parkway Blvd
MěstoSALT LAKE CITY
PSČ84120-6336
ZeměUnited States
Kontatní osoba 
Funkce kontaktní osoby 
Telefon18 019 547 100
Fax18019569486

Business Summary: USANA Health Sciences, Inc. and subsidiaries is a global nutrition, personal health and wellness company that develops and manufactures science-based nutritional and personal care products. Its segments include Direct selling and Hiya direct-to-consumer. The Direct Selling segment develops and manufactures science-based nutritional, personal care and skincare products with a primary focus on promoting long-term health and wellness in various geographic markets worldwide that are distributed through the direct selling channel. The Hiya direct-to-consumer segment is a provider of children’s health and wellness products in the United States that are distributed through the direct-to-consumer channel. Its product line includes USANA Nutritionals Optimizers, Essentials/CellSentials, and Foods. USANA Nutritionals Optimizers products include Proflavanol, CoQuinone 30, and BiOmega-3. Essentials/CellSentials products include USANA CellSentials and HealthPak 100.
Financial Summary: BRIEF: For the three months ended 29 March 2025, USANA Health Sciences Inc revenues increased 10% to $249.5M. Net income decreased 43% to $9.4M. Revenues reflect All other segment increase of 21% to $2M, Americas and Europe segment increase of 78% to $76.1M. Net income was offset by Direct selling segment income decrease of 32% to $17.5M, All other segment loss increase of 39% to $1.3M.
Odvětvová klasifikace
TRBC2009Personal Products
TRBC2012Special Foods & Wellbeing Products
RBSS2004Personal Products
MGINDUSTRYBiotechnology & Drugs
MGSECTORHealthcare
NAICSMedicinal and Botanical Manufacturing
NAICSPharmaceutical Preparation Manufacturing
NAICSToilet Preparation Manufacturing
NAICSResearch and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
NAICS2007Medicinal & Botanical Mfg
NAICS2007Pharmaceutical Preparation Mfg
NAICS2007Toilet Preparation Manufacturing
NAICS2007Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)
NAICS1997Medicinal and Botanical Manufacturing
NAICS1997Pharmaceutical Preparation Manufacturing
NAICS1997Toilet Preparation Manufacturing
NAICS1997Research and Development in the Physical, Engineering, and Life Sciences
SICMedicinals And Botanicals
SICMedicinals And Botanicals
SICPharmaceutical Preparations
SICToilet Preparations
SICCommercial Physical Research



  • Poslední aktualizace: 12.06.2025
Management společnosti
FunkceJménoVěkVe funkci odVe firmě od
Executive Chairman of the BoardKevin Guest6101.07.2023
President, Chief Executive OfficerJim Brown5501.07.2023
Chief Financial OfficerG. Hekking5402.05.201710.05.2011
Chief Operating OfficerWalter Noot58
Chief People OfficerPaul Jones6014.12.2012
Chief Communications and Marketing OfficerDaniel Macuga5401.01.2011
Chief Scientific OfficerKathryn Armstrong-22.01.202522.01.2025
Chief Legal Officer, General Counsel and Corporate SecretaryP. Joshua Foukas48
Chief Sales OfficerDavid Mulham6308.02.2017
Chief Commercial OfficerBrent Neidig40